Early antibiotic discontinuation in patients with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoscopy cultures

Critical Care Medicine

Volumn 41, Issue 7, 2013, Pages 1656-1663

  Raman, Kirthana ^a,b,c   Nailor, Michael D ^a,b   Nicolau, David P ^a   Aslanzadeh, Jaber ^a   Nadeau, Michelle ^b   Kuti, Joseph L ^a  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

antimicrobial stewardship; bronchoalveolar lavage; quantitative culture; superinfection; ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BACTEREMIA; BACTERIURIA; BRONCHOSCOPY; COLONY FORMING UNIT; COMORBIDITY; CULTURE TECHNIQUE; DRUG WITHDRAWAL; FEMALE; HOSPITALIZATION; HUMAN; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; SEPSIS; SUPERINFECTION; TREATMENT DURATION; TREATMENT WITHDRAWAL; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; ANTI-BACTERIAL AGENTS; APACHE; BRONCHOALVEOLAR LAVAGE FLUID; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITAL MORTALITY; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; RETROSPECTIVE STUDIES; SUPERINFECTION;

EID: 84880573409     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318287f713     Document Type: Article

References (32)

1. American Thoracic Society and Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
2. Cardo D, Horan T, Andrus M, et al: National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485
3. Vincent JL, Bihari DJ, Suter PM, et al: The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274:639-644
4. Rello J, Ollendorf DA, Oster G, et al; VAP Outcomes Scientific Advisory Group: Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122:2115-2121
5. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903
6. Rello J, Ausina V, Ricart M, et al: Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104:1230-1235
7. Heyland DK, Cook DJ, Griffith L, et al: The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159(4 Pt 1):1249-1256
8. Dellit TH, Owens RC, McGowan JE, et al: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Inf Dis 2007; 44:159-177
9. Eagye KJ, Nicolau DP, Kuti JL: Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia. Semin Respir Crit Care Med 2009; 30:116-123
10. Bonten MJ, Bergmans DC, Stobberingh EE, et al: Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use. Am J Respir Crit Care Med 1997; 156:1820-1824
11. Fagon JY, Chastre J, Wolff M, et al: Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 2000; 132:621-630
12. Shorr AF, Sherner JH, Jackson WL, et al: Invasive approaches to the diagnosis of ventilator-associated pneumonia: A meta-analysis. Crit Care Med 2005; 33:46-53
13. de Jaeger A, Litalien C, Lacroix J, et al: Protected specimen brush or bronchoalveolar lavage to diagnose bacterial nosocomial pneumonia in ventilated adults: A meta-analysis. Crit Care Med 1999; 27:2548-2560
14. Heyland D, Dodek P, Muscedere J, et al: Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilatorassociated pneumonia. NEJM 2006; 355:2619-2630
15. Baker AM, Bowton DL, Haponik EF: Decision making in nosocomial pneumonia. An analytic approach to the interpretation of quantitative bronchoscopic cultures. Chest 1995; 107:85-95
16. Brun-Buisson C, Fartoukh M, Lechapt E, et al: Contribution of blinded, protected quantitative specimens to the diagnostic and therapeutic management of ventilator-associated pneumonia. Chest 2005; 128:533-544
17. Chastre J, Combes A, Luyt CE: The invasive (quantitative) diagnosis of ventilator-associated pneumonia. Respir Care 2005; 50:797-807
18. Croce MA, Fabian TC, Mueller EW, et al: The appropriate diagnostic threshold for ventilator-associated pneumonia using quantitative cultures. J Trauma 2004; 56:931-936
19. Labelle AJ, Arnold H, Reichley RM, et al: A comparison of culture-positive and culture-negative health-care-associated pneumonia. Chest 2010; 137:1130-1137
20. El Solh AA, Akinnusi ME, Alfarah Z, et al: Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home-acquired pneumonia. J Am Geriatr Soc 2009; 57:1030-1035
21. Kollef MH, Kollef KE: Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results. Chest 2005; 128:2706-2713
22. Singh N, Rogers P, Atwood CW, et al: Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. Am J Respir Crit Care Med 2000; 162:505-511
23. Micek ST, Ward S, Fraser VJ, et al: A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilatorassociated pneumonia. Chest 2004; 125:1791-1799
24. Niederman MS: The argument against using quantitative cultures in clinical trials and for the management of ventilator-associated pneumonia. Clin Infect Dis 2010; 51 Suppl 1:S93-S99
25. Fujitani S, Yu VL: Quantitative cultures for diagnosing ventilator-associated pneumonia: A critique. Clin Infect Dis 2006; 43:S106-S113
26. Luna CM, Chirino A: Qualitative cultures in ventilator-associated pneumonia - Can they be used with confidence? Crit Care 2004; 8:425-426
27. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
28. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22:707-710
29. Pugin J, Auckenthaler R, Mili N, et al: Diagnosis of ventilator- associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143(5 Pt 1):1121-1129
30. Dennesen PJ, van der Ven AJ, Kessels AG, et al: Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001; 163:1371-1375
31. Chastre J, Wolff M, Fagon JY, et al; PneumA Trial Group: Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290:2588-2598
32. Ibrahim EH, Ward S, Sherman G, et al: Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29:1109-1115